ERBB2 and breast carcinoma: 44 Lidbrink Lidbrink E E Chmielowska Chmielowska E E Otremba Otremba B B Bouhlel Bouhlel A A Lauer Lauer S S Liste Hermoso Liste Hermoso M M A real-world study of cardiac events in > 3700 patients with HER2-positive early breast cancer treated with trastuzumab: final analysis of the OHERA study A real-world study of cardiac events in > 3700 patients with HER2-positive early breast cancer treated with trastuzumab: final analysis of the OHERA study Breast Cancer Res Treat Breast Cancer Res Treat 2019 2019 174 174 1 1 187 187 196 196 30506110 30506110 44.